Yoeri Bemelmans

Chapter 3 42 References 1. Abdel MP, Chalmers BP, Taunton MJ, et al. (2018) Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty: Both Effective in a Randomized Clinical Trial of 640 Patients. J Bone Joint Surg Am. 100(12):1023-1029 2. Balachandar G, Abuzakuk T (2019) Is there an optimal timing of administration of single-dose intravenous tranexamic acid in bilateral total knee arthroplasty? A comparison between preoperative and intraoperative dose. J Orthop Surg 2019. 27(3):2309499019880915 3. Barrachina B, Lopez-Picado A, Remon M, et al. (2016) Tranexamic Acid Compared with Placebo for Reducing Total Blood Loss inHip Replacement Surgery: A Randomized Clinical Trial. Anesth Analg. 122(4):986–995 4. Basora M, Tió M, Martin N, et al. (2014) Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty? Vox Sang. 107(2):148–152 5. Bowditch MG, Villar RN (1999) Do obese patients bleed more? A prospective study of blood loss at total hip replacement. Ann R Coll Surg Engl. 81:198–200 6. Carling MS, Jeppsson A, Eriksson BI, Brisby H (2015) Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 10:48 7. Clavé A, Gérard R, Lacroix J, et al. (2019) A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. Bone Joint J. 101–B(2):207–212 8. Dastrup A, Pottegård A, Hallas J, Overgaard S (2018) Perioperative Tranexamic Acid Treatment and Risk of Cardiovascular Events or Death After Total Hip Arthroplasty: A Population-Based Cohort Study from National Danish Databases. J Bone Joint Surg Am. 100(20):1742–1749 9. Duncan CM, Gillette BP, Jacob AK, et al. (2015) Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty. 30(2):272–276 10. FillinghamYA, Ramkumar DB, Jevsevar DS, et al. (2018) The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis. J Arthroplasty. 33(10):3070–3082.e1 11. Fillingham YA, Ramkumar DB, Jevsevar DS, et al. (2018) The Efficacy of Tranexamic Acid in Total Knee Arthroplasty: A Network Meta-Analysis. J Arthroplasty. 33(10):3090–3098.e1 12. FrischNB, Wessell NM, ChartersMA, et al. (2014) Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplasty. 29(9 Suppl):189–192 13. Guay J (2016) The effect of neuraxial blocks on surgical blood loss and blood transfusion requirements: a meta-analysis. J Clin Anesth.18(2):124-8 14. Jiang T, Song K, Yao Y, Pan P, Jiang Q (2019) Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty. J Orthop Surg Res. 14(1):235 15. Johansson T, Pettersson LG, Lisander B (2005) Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 76(3):314–319 16. Jung WH, Chun CW, Lee JH, et al. (2013) No difference in total blood loss, haemoglobin and haematocrit between continues and intermittent wound drainage after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 21(12):2831-6 17. Kim JL, Park JH, Han SB, Cho IY, Jang KM (2017) Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical-Site Infection Following Total Hip and Knee Arthroplasty: A Meta-Analysis. J Arthroplasty. 32(1):320–325